A detailed history of Burney CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Burney CO holds 15,991 shares of TGTX stock, worth $495,721. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,991
Previous 42,976 62.79%
Holding current value
$495,721
Previous $1.55 Million 62.68%
% of portfolio
0.02%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 16, 2025

SELL
$26.39 - $39.19 $712,134 - $1.06 Million
-26,985 Reduced 62.79%
15,991 $577,000
Q2 2025

Aug 05, 2025

SELL
$33.37 - $45.51 $35,038 - $47,785
-1,050 Reduced 2.38%
42,976 $1.55 Million
Q1 2025

May 06, 2025

SELL
$27.67 - $42.99 $23,768 - $36,928
-859 Reduced 1.91%
44,026 $1.74 Million
Q4 2024

Jan 14, 2025

SELL
$21.31 - $35.09 $8,843 - $14,562
-415 Reduced 0.92%
44,885 $1.35 Million
Q3 2024

Oct 18, 2024

BUY
$17.21 - $25.28 $5,197 - $7,634
302 Added 0.67%
45,300 $1.06 Million
Q2 2024

Jul 29, 2024

BUY
$13.32 - $19.19 $599,373 - $863,511
44,998 New
44,998 $800,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Burney CO Portfolio

Follow Burney CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.